Monte Rosa Therapeutics, Inc. PS Ratio 2021–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Monte Rosa Therapeutics, Inc. (GLUE): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 13.13.

From: 03/31/2024To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Monte Rosa Therapeutics, Inc. PS Ratio — FAQ

Monte Rosa Therapeutics, Inc. (GLUE) ps ratio over the last 3 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see GLUE's ps ratio history?

The chart and table above show Monte Rosa Therapeutics, Inc.'s ps ratio by year and by quarter, including the growth rate.